Serious adverse events included 1 case of thrombocytopenia with negative HIT serology results and 1 case of rectus sheath hematoma, both in the therapeutic-dose group. In the per-protocol population, therapeutic-dose LMWH reduced the incidence of the primary efficacy outcome (48.0% vs 30.1%; RR,...
Hepatitis C Virus (HCV) disproportionately affects people who inject drugs, migrants, prisoners and the homeless. An integrated, peer-led model of care involving primary and secondary care is required to enhance the identification and treatment of HCV in